000144847 001__ 144847
000144847 005__ 20240229112639.0
000144847 0247_ $$2doi$$a10.18632/oncotarget.27198
000144847 0247_ $$2pmid$$apmid:31534634
000144847 0247_ $$2pmc$$apmc:PMC6739213
000144847 037__ $$aDKFZ-2019-02271
000144847 041__ $$aeng
000144847 082__ $$a610
000144847 1001_ $$aChretien, Anne-Sophie$$b0
000144847 245__ $$aCorrection: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
000144847 260__ $$a[S.l.]$$bImpact Journals LLC$$c2019
000144847 3367_ $$2DRIVER$$aarticle
000144847 3367_ $$2DataCite$$aOutput Types/Journal article
000144847 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1569222351_11274$$xErratum/Correction
000144847 3367_ $$2BibTeX$$aARTICLE
000144847 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144847 3367_ $$00$$2EndNote$$aJournal Article
000144847 520__ $$a[This corrects the article DOI: 10.18632/oncotarget.17747.].
000144847 536__ $$0G:(DE-HGF)POF3-314$$a314 - Tumor immunology (POF3-314)$$cPOF3-314$$fPOF III$$x0
000144847 588__ $$aDataset connected to CrossRef, PubMed,
000144847 7001_ $$aFauriat, Cyril$$b1
000144847 7001_ $$aOrlanducci, Florence$$b2
000144847 7001_ $$aRey, Jerome$$b3
000144847 7001_ $$aBorg, Gaelle Bouvier$$b4
000144847 7001_ $$aGautherot, Emmanuel$$b5
000144847 7001_ $$aGranjeaud, Samuel$$b6
000144847 7001_ $$aDemerle, Clemence$$b7
000144847 7001_ $$aHamel, Jean-François$$b8
000144847 7001_ $$0P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f$$aCerwenka, Adelheid$$b9$$udkfz
000144847 7001_ $$avon Strandmann, Elke Pogge$$b10
000144847 7001_ $$aIfrah, Norbert$$b11
000144847 7001_ $$aLacombe, Catherine$$b12
000144847 7001_ $$aCornillet-Lefebvre, Pascale$$b13
000144847 7001_ $$aDelaunay, Jacques$$b14
000144847 7001_ $$aToubert, Antoine$$b15
000144847 7001_ $$aArnoulet, Christine$$b16
000144847 7001_ $$aVey, Norbert$$b17
000144847 7001_ $$aOlive, Daniel$$b18
000144847 773__ $$0PERI:(DE-600)2560162-3$$a10.18632/oncotarget.27198$$gVol. 10, no. 52$$n52$$p5493$$tOncoTarget$$v10$$x1949-2553$$y2019
000144847 909CO $$ooai:inrepo02.dkfz.de:144847$$pVDB
000144847 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000144847 9131_ $$0G:(DE-HGF)POF3-314$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTumor immunology$$x0
000144847 9141_ $$y2019
000144847 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144847 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144847 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144847 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000144847 9201_ $$0I:(DE-He78)D080-20160331$$kD080$$lNachwuchsgruppe Angeborene Immunität$$x0
000144847 980__ $$ajournal
000144847 980__ $$aVDB
000144847 980__ $$aI:(DE-He78)D080-20160331
000144847 980__ $$aUNRESTRICTED